Please check your internet connection and try again.
# Acetylcysteine
## Overview
Acetylcysteine is a mucolytic agent and an antidote for acetaminophen overdose. It works by breaking disulfide bonds in mucoproteins, decreasing mucus viscosity, and by replenishing hepatic glutathione stores.
## Primary Indications
* Acetaminophen overdose
* Adjunct therapy in patients with a lung disease such as chronic obstructive pulmonary disease (COPD), bronchitis, or cystic fibrosis to help loosen mucus secretions.
## Adult Dosing
**Acetaminophen Overdose:**
* **IV Administration:** Typically a 3-bag, 72-hour regimen.
* **Loading Dose:** 150 mg/kg IV over 1 hour.
* **Second Infusion:** 50 mg/kg IV over the next 1 hour (maximum 6.25 g/hr).
* **Third Infusion:** 100 mg/kg IV over the next 16 hours (maximum 12.5 g/hr).
* *Note: Specific concentrations and infusion rates vary based on protocol and product availability. Consult local protocol.*
* **Oral Administration:** Typically a 3-bag, 72-hour regimen.
* **Loading Dose:** 140 mg/kg PO.
* **Subsequent Doses:** 70 mg/kg PO every 4 hours for 17 doses.
* Dilute in 5% dextrose or fruit juice to improve palatability.
**Mucolytic:**
* **Nebulized:** 20% solution: 1-10 mL once to several times daily. 10% solution: 2-10 mL once to several times daily.
* **Oral:** 200 mg twice daily to 1000 mg twice daily.
## Pediatric Dosing
**Acetaminophen Overdose:**
* **IV Administration:** Dosing is the same as adults (150 mg/kg loading, then 50 mg/kg, then 100 mg/kg). Due to the risk of anaphylactoid reactions, slow infusion rate in children if higher concentrations are used, or consider diluting further.
* **Oral Administration:** Dosing is the same as adults (140 mg/kg loading, then 70 mg/kg PO every 4 hours for 17 doses).
**Mucolytic:**
* **Nebulized:**
* **< 1 year:** 1-2 mL of 20% solution or 2-4 mL of 10% solution every 2-6 hours.
* **1-12 years:** 2-10 mL of 20% solution or 4-10 mL of 10% solution every 2-6 hours.
* **> 12 years:** Same as adult dosing.
* **Oral:** Dosing is less established and varies. Commonly used doses range from 100 mg to 200 mg twice daily in younger children, up to adult doses in older children and adolescents.
## Dose Adjustments
No dose adjustments are typically required for hepatic or renal impairment for the antidote indication. For mucolytic use, doses may be adjusted based on patient response and tolerance.
## Contraindications
* Hypersensitivity to acetylcysteine or any component of the formulation.
* Active hemorrhage (relative contraindication for nebulized use if significant hemoptysis).
## Adverse Effects
* **IV (Overdose):** Anaphylactoid reactions (rash, pruritus, bronchospasm, angioedema, hypotension) are common and typically related to infusion rate. Nausea and vomiting.
* **Nebulized:** Bronchospasm, stomatitis, rhinorrhea, nausea.
* **Oral:** Nausea, vomiting, diarrhea, abdominal pain.
## Key Drug Interactions
* **Activated Charcoal:** Decreases absorption of oral acetylcysteine. If both are used, administer charcoal first and then acetylcysteine 1 hour later.
* **Nitroglycerin:** May potentiate hypotensive effects.
## Monitoring
* **Acetaminophen Overdose:**
* Liver function tests (ALT, AST, bilirubin, INR).
* Renal function.
* Serum acetaminophen levels.
* Monitor for signs of anaphylactoid reaction (vital signs, respiratory status).
* **Mucolytic Use:**
* Respiratory status, sputum production, and viscosity.
* Monitor for bronchospasm.
## Clinical Pearls
* For IV acetylcysteine in acetaminophen overdose, the antidote effect is most pronounced when initiated within 8-10 hours of ingestion. However, it should be given regardless of time elapsed if acetaminophen levels are in the treatment nomogram range or if level is unavailable.
* Anaphylactoid reactions are common but usually manageable by slowing the infusion rate. Antihistamines may be used for prophylaxis or treatment.
* Oral acetylcysteine may be an alternative if IV access is difficult or if IV product is unavailable, but it has a higher incidence of nausea and vomiting.
* Nebulized acetylcysteine can sometimes worsen bronchospasm; co-administration with a bronchodilator is often recommended.
***
**Disclaimer:** This information is intended for educational purposes only and does not constitute medical advice. Always consult the most current prescribing information, guidelines, and institutional protocols before making clinical decisions.